ERCC1 and gastric adenocarcinoma: In this study, we found that ERCC1 rs2298881C and rs11615A variant genotypes were associated with a pronounced increased risk of gastric adenocarcinoma and that the increased risk associated with 2–3 risk genotypes was more evident in never drinkers, NGCA and clinical stage I+II.